Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

IMCR stock hub

Immunocore Holdings plc has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IMCRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.5B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

IMCR

In the news

Latest news · IMCR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-7.1

P25 -105.6P50 -46.5P75 -3.1

ROIC-1.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IMCR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

215

Groups with data

Currency

USD

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001671927
Company name	Immunocore Holdings plc
Country	United Kingdom
Country code	US
Cusip	45258D105
Employees	524
Employees Change	31%
Employees Change Percent	6.29
Enterprise value	$1.1B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-02-05
Isin	US45258D1054
Last refreshed	2026-05-10
Market cap	$1.5B
Market cap category	Small-Cap
Price	$29.58
Price currency	USD
Rev Per Employee	787,809.16x
Sector	Healthcare
Sic	2836
Symbol	IMCR
Website	https://www.immunocore.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.83%
EV Sales Forward	2.31x
EV/Sales	2.65x
FCF yield	-2.04%
P/B ratio	3.81x
P/S ratio	3.64x
PS Forward	3.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-3.57%
EBITDA Margin	-2.75%
Gross margin	96.74%
Gross Profit	$399.3M
Gross Profit Growth	23.83%
Gross Profit Growth Q	14.18%
Gross Profit Growth3 Y	67.67%
Net Income	$-27.6M
Net Income Growth Q	158.23%
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Pretax Margin	-2.89%
Profit Margin	-6.68%
Profit Per Employee	$-52,607
ROA	-0.88
Roa5y	-10.32
ROCE	-1.77
ROE	-7.14
Roe5y	-34.96
ROIC	-1.12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-1.14%
Cagr3y	-20.92%
Cagr5y	-6%
EPS Growth Q	150
EPS Growth Quarters	1
EPS Growth Years	4
Revenue Growth	23.75x
Revenue Growth Q	13.63x
Revenue Growth Quarters	18x
Revenue Growth Years	4x
Revenue Growth3 Y	27.07x
Revenue Growth5 Y	58.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.39
Assets	$1.1B
Cash	$844.9M
Current Assets	$1B
Current Liabilities	$240.1M
Debt	$435.7M
Debt Equity	$1.11
Equity	$393.7M
Interest Coverage	-1.21
Liabilities	$678.4M
Long Term Assets	$68.3M
Long Term Liabilities	$438.3M
Net Cash	$409.2M
Net Cash By Market Cap	$27.22
Net Cash Growth	1.53%
Net Debt Equity	$-1.04
Tangible Book Value	$393.7M
Tangible Book Value Per Share	$7.76
WACC	6.96

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.18
Inventory Turnover	1.79
Net Working Capital	$-79.2M
Quick ratio	3.86
Working Capital	$763.7M
Working Capital Turnover	$0.53

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.94%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-1.14%
200-day SMA	33.33
3Y total return	-50.56%
50-day SMA	30.7
50-day SMA vs 200-day SMA	50under200
5Y total return	-26.62%
All Time High	76.98
All Time High Change	-61.57%
All Time High Date	2024-02-01
All Time Low	18.43
All Time Low Change	60.5%
All Time Low Date	2022-01-21
ATR	1.31
Beta	0.74
Beta1y	0.64
Beta2y	0.65
Ch YTD	-14.78
High	30.65
High52	40.72
High52 Date	2025-12-05
High52ch	-27.35%
Low	29.51
Low52	27.44
Low52 Date	2025-05-15
Low52ch	7.8%
Ma50ch	-3.64%
Premarket Change Percent	1.24
Premarket Price	$31
Premarket Volume	794
Price vs 200-day SMA	-11.24%
RSI	47.39
RSI Monthly	42.75
RSI Weekly	41.92
Sharpe ratio	0.08x
Sortino ratio	0.28
Total Return	-0.94%
Tr YTD	-14.78
Tr1m	-7.45%
Tr1w	5.04%
Tr3m	-7.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	5
Analyst Price Target Top	$83.75
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.26
Earnings Revenue Estimate	107,422,928x
Earnings Revenue Estimate Growth	14.42x
Operating Income	$-14.7M
Operating margin	-3.57
Price target	$65.57
Price Target Change	$122
Price Target Change Top	$183

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	45,192,347%
Float Percent	88.91%
Shares Insiders	0.07%
Shares Institutions	86.19%
Shares Out	50,831,528
Shares Qo Q	4.89%
Shares Yo Y	0.94%
Short Ratio	23.38
Short Shares	21.41

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-65.3M
Average Volume	396,791.6x
Bv Per Share	7.76
CAPEX	$-5.8M
Ch1m	-7.45
Ch1w	5.04
Ch1y	-1.14
Ch3m	-7.5
Ch3y	-50.56
Ch5y	-26.62
Ch6m	-11.7
Change	-3.4%
Change From Open	-3.4
Close	30.62
Days Gap	0
Depreciation Amortization	3,360,000
Dollar Volume	3,845,902.9
Earnings Date	2026-05-06
Earnings Time	bmo
EBIT	$-14.7M
EBITDA	$-11.4M
EPS	$-0.55
F Score	3
FCF	$-30.7M
FCF EV Yield	-2.81x
FCF Per Share	$-0.6
Financing CF	10,476,000
Fiscal Year End	December
Founded	2,008
Income Tax	$15.7M
Investing CF	-21,823,000
Ipr	13.77
Iprfo	-27.85
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-25
Ma150	33.19
Ma150ch	-10.87%
Ma20	29.84
Ma20ch	-0.86%
Net CF	-24,170,000
Next Earnings Date	2026-08-06
Open	30.62
Optionable	Yes
Position In Range	6.14
Post Close	29.58
Postmarket Change Percent	-0.17
Postmarket Price	$29.53
Ppne	49,674,000
Pre Close	30.62
Price Date	2026-05-08
Ptbv Ratio	3.82
Relative Volume	0.33x
Revenue	412,812,000x
SBC By Revenue	8.36x
Share Based Comp	34,511,000
Tax By Revenue	3.79x
Tr6m	-11.7%
Volume	130,017

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IMCR pay a dividend?

Capital-return profile for this ticker.

Performance

IMCR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IMCR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+86.2%

Float: +88.9% of shares outstanding

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

IMCR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.4

Neutral momentum band

Price vs 200-day MA

-11.2%

50/200-day relationship not available

Beta (5Y)

0.74

Less volatile than the market

Sharpe ratio

0.08

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IMCR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IMCR stock rating?

Immunocore Holdings plc is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IMCR analysis?

The full report lives at /stocks/IMCR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IMCR?

The latest report frames IMCR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IMCR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.